Beranda › Leukemia Limfositik Kronis › California › Mountain View
Uji klinis Leukemia Limfositik Kronis di Mountain View, CA
7 studi untuk Leukemia Limfositik Kronis mencari peserta di lokasi sekitar Mountain View (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
Menerima pesertaFase 3
- Stanford Cancer Institute, Palo Alto · 5 mi jauhnya
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Menerima pesertaFase 1/2
- Stanford Medicine, Palo Alto · 5 mi jauhnya
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
Menerima pesertaFase 3
- Stanford Cancer Institute, Palo Alto · 5 mi jauhnya
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Menerima pesertaFase 3
- Stanford Cancer Institute, Palo Alto · 5 mi jauhnya
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Menerima pesertaFase 3
- Stanford School of Medicine-Cancer Clinical Trials Office, Palo Alto · 5 mi jauhnya
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Menerima pesertaFase 2
- Palo Alto Medical Foundation Research Institute (PAMFRI), Palo Alto · 5 mi jauhnya
- Stanford Cancer Center, Palo Alto · 5 mi jauhnya
Acalabrutinib, Venetoclax and Durvalumab for the Treatment of Richter Transformation From Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Menerima pesertaFase 2
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 mi jauhnya
Uji klinis Leukemia Limfositik Kronis di kota lain
- Boston, MA31 studi
- Columbus, OH28 studi
- Durham, NC27 studi
- Washington, DC22 studi
- Seattle, WA20 studi
- Rochester, MN19 studi
- New York City, NY18 studi
- Houston, TX17 studi
- Baldwin Park, CA16 studi
- Milwaukee, WI15 studi
- Chicago, IL14 studi
- Cincinnati, OH14 studi
Studi lain di Mountain View
- Kanker (semua jenis)40 studi
- Kanker Payudara25 studi
- Kanker Metastatik25 studi
- Kanker Paru Non-Sel Kecil21 studi
- Leukemia Mieloid Akut19 studi
- Kanker Ovarium19 studi
- Gangguan Spektrum Autisme17 studi
- Kanker Paru17 studi
- Gagal Jantung15 studi
- Kanker Prostat15 studi
- Autisme13 studi
- Leukemia Limfoblastik Akut13 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.